LUCADALUCADA

Jacqueline BrownCancer Services Manager

North Tees & Hartlepool Trust

BackgroundBackground• 93% of expected new lung cancers have

been recorded on LUCADA for the last report – over 38,000 cases

• Starting to produce some valuable information

• Some reports and data sources are using older data

AuditAudit• LUCADA Annual Report

– Discussion at MDT– Mesothelioma patients– Surgical Resection Rates– Small Cell Chemotherapy– Data completeness

What can you get out of What can you get out of LUCADALUCADA

• Survival

– LUCADA data goes back to 2004

•7 years of 1 year and 6 month survival

•3 years of 5 year survival

One Year SurvivalOne Year Survival

05

10152025303540

2004 2005 2006 2007 2008 2009 2010

% o

f pat

ient

s

UHNTUHHAll

ComparisonsComparisons8.1 Diagnostic and Staging Investigations

Total number of patients registered 180    

No. Patients (RVWAE) (RVWAE)(ALL_ORGS)CT scan 177 98.3% 83.8% PET or PET/CT Scan 74 41.1% 23.4% Bronchoscopy57 31.7% 34.6% Diagnostic Biopsy 57 31.7% 18.1% CT Guided Biopsy 39 21.7% 17.5%

ComparisonsComparisons2.2 Time to first appointment from first referral to specialistteamTotal number of patients registered 170    No. Patients RVWAE ALL_ORGSTime to first appointment  6.0 Days 7.0 Days

2.3 Time to diagnosis from first referral to specialist teamTotal number of patients registered 170    No. Patients RVWAE ALL_ORGSTime to diagnosis  14.0 Days 20.0 Days

LUCADA Data PacksLUCADA Data Packs• Information on your Trust• Information on Network – can compare

where you stand against different Trusts• Ranks your Trust nationally

– 2.07 – Percentage receiving surgery all cases– The percentage of all lung cancers patients including mesothelioma cases recorded as

receiving surgery as treatment– National ranking for RVW - North Tees and Hartlepool NHS Trust: 41 of 167

1.06 - PS & Stage completeness (percentage)The percentage of cases where both the performance status and staging fields have been completed

Data Last Refreshed: 22 December 2011Available Data: 2007, 2008 and 2009Next Data Update: December 2011Source: National Lung Cancer Audit

1.06 - PS & Stage completeness (percentage)The percentage of cases where both the performance status and staging fields have been completed

Source: National Lung Cancer Audit

Make a noteMake a note• For the future

– It is anticipated that data on co-morbidities will be included in future case-mix adjustments

– It is anticipated that date on Lung Function Tests – FEV1 absolute and percentage will be included in future case mix adjustments

Useful PlacesUseful Places• https://nlcadatapacks.ic.nhs.uk/

default.aspx

European StudyEuropean Study• ERS taskforce for Quality Management in Lung

Cancer Care • To assess the feasibility of collecting

prospective data on lung cancer patients in multiple European countries

• Use data collected routinely via the National Lung Cancer Audit

• Patients diagnosed between the 1st and 31st May 2012 could be uploaded onto the NLCA system by the end of June 2012

Thank youThank you